Queen’s scientist makes major cystic fibrosis breakthrough
A Queen’s University doctor has played a key role in a major breakthrough to change the lives of cystic fibrosis sufferers
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
FDA approves Lymphoseek for head and neck cancer determination
The most common side effects identified in clinical trial was pain or irritation at the injection site
FDA approves Afrezza to treat diabetes
The US Food and Drug Administration approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve…
FDA approves Beleodaq
The US Food and Drug Administration approved Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma…
Will India’s IP law and policy ‘Modi-fy’?
Yogesh Pai, Assistant Professor of Law at National Law University, Delhi, says that greater certainty and predictability in IP law…
Healing the World
Express Pharma’s CSR Special spotlights initiatives beyond medicines that heal the world
Biogen Idec: Caring deeply
Biogen Idec prides itself in the business of transforming lives of patients. Corporate citizenship is deeply ingrained into the…
Boehringer Ingelheim India: Empowering changemakers
Innovation is intrinsic to human nature but very often, the impact of these remain restricted to a small circle. A…
Indoco: Remedies beyond prescription
The Companies Bill 2012 makes it compulsory for the corporate houses to indulge in Corporate Social Responsibility (CSR)…
Novartis: Making a difference
Novartis India is globally known for its quality medicines. The company has managed to save millions of lives across the globe…